Published in J Intern Med on February 23, 2011
Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa. Int J Infect Dis (2014) 0.83
Evaluation of the economic burden of Herpes Zoster (HZ) infection. Hum Vaccin Immunother (2015) 0.83
Post-herpetic neuralgia. Int J Gen Med (2012) 0.82
Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over. Drugs Aging (2013) 0.80
[Postherpetic neuralgia]. Schmerz (2014) 0.79
Vaccination of Adult Patients with Systemic Lupus Erythematosus in Portugal. Int J Rheumatol (2016) 0.75
Presentation and management of herpes zoster (shingles) in the geriatric population. P T (2013) 0.75
The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00
THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med (1965) 10.85
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2008) 6.18
The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78
The incidence of herpes zoster. Arch Intern Med (1995) 3.87
Disturbances in gamma globulin synthesis as experiments of nature. Pediatrics (1956) 3.18
Herpes zoster and human immunodeficiency virus infection. J Infect Dis (1992) 3.04
Varicella: report of two fatal cases with necropsy, virus isolation, and serologic studies. Am J Pathol (1957) 3.02
Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry (2001) 3.00
Zoster sine herpete, a clinical variant. Ann Neurol (1994) 2.84
Zoster sine herpete. Br Med J (1958) 2.83
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology (2007) 2.76
Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med (2002) 2.73
Immune responses to varicella-zoster in the aged. Arch Intern Med (1982) 2.59
Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol (2004) 2.51
Two patients with unusual forms of varicella-zoster virus vasculopathy. N Engl J Med (2002) 2.46
Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology (2010) 2.45
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis (2007) 2.19
Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med (2001) 2.18
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis (2009) 2.13
Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine (2007) 2.01
Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke (2009) 1.88
Herpes Zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci (1972) 1.76
Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Ann Intern Med (2006) 1.74
Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis (1986) 1.72
Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol (2008) 1.71
Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia. J Virol (2009) 1.63
Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol (1983) 1.60
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales. Vaccine (2009) 1.55
Varicella-zoster virus myelitis: an expanding spectrum. Neurology (1994) 1.53
Ramsay Hunt facial paralysis: clinical analyses of 185 patients. Otolaryngol Head Neck Surg (1986) 1.45
The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage (1997) 1.44
VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology (2007) 1.41
Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine (2008) 1.38
Herpes zoster myelitis. Brain (1991) 1.36
The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia. Hum Vaccin (2010) 1.32
Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain (1991) 1.30
Prolonged herpes-zoster infection associated with immunosuppressive therapy. Ann Intern Med (1979) 1.25
Herpes zoster in children. J Am Acad Dermatol (1998) 1.25
Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis (1998) 1.20
Zoster myelitis: improvement with antiviral therapy in two cases. Neurology (1996) 1.19
Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol (1995) 1.18
VZV T cell-mediated immunity. Curr Top Microbiol Immunol (2010) 1.17
Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods (1994) 1.16
Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV. Ann Neurol (2003) 1.16
Management of varicella zoster virus retinitis in AIDS. Br J Ophthalmol (1997) 1.16
Necrotizing herpetic retinopathies. A spectrum of herpes virus-induced diseases determined by the immune state of the host. Ocul Immunol Inflamm (1997) 1.14
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine (2009) 1.12
Peripheral blood mononuclear cells of the elderly contain varicella-zoster virus DNA. J Infect Dis (1992) 1.12
Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J (2005) 1.09
Pathology of the human spinal ganglia in varicella-zoster virus infection. Acta Neuropathol (1975) 1.08
Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman. J Neurovirol (2009) 1.07
Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete. J Med Virol (1998) 1.07
Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia. Proc Natl Acad Sci U S A (1988) 1.05
Varicella vaccine in the United States: a decade of prevention and the way forward. J Infect Dis (2008) 1.02
Acute cerebellar ataxia in a 41 year old woman. Lancet Neurol (2006) 1.02
Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination. J Infect Dis (2003) 1.01
Varicella zoster virus cerebellitis in a 66-year-old patient without herpes zoster. Lancet (2006) 1.01
Segmental abdominal herpes zoster paresis. Aust N Z J Surg (1986) 1.01
Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. AIDS (2002) 1.01
Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J Infect Dis (1997) 1.01
National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J Infect Dis (2008) 0.99
Cervical herpes zoster and diaphragmatic paralysis. Br J Dis Chest (1969) 0.99
Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes (2007) 0.99
Segmental zoster paresis of the upper extremity: a case report. Arch Phys Med Rehabil (2005) 0.99
Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections. Infect Immun (1979) 0.98
Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch Neurol (2006) 0.98
Spinal ganglion in herpes zoster. A light and electron microscopic study. Arch Pathol (1973) 0.98
Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine. Vaccine (2007) 0.95
Post-herpetic neuralgia: post-mortem analysis of a case. Pain (1988) 0.94
[Myelitis and optic neuritis caused by varicella]. Rev Neurol (1997) 0.94
Optic neuropathy and ophthalmoplegia in herpes zoster oticus. Neurology (1979) 0.92
Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J Neurol Sci (2002) 0.92
Tooth exfoliation, osteonecrosis and neuralgia following herpes zoster of trigeminal nerve. Indian J Dent Res (2002) 0.91
Varicella-zoster virus meningoencephalitis in an immunocompetent patient without a rash. Scand J Infect Dis (2010) 0.90
Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome. Ann Neurol (1998) 0.90
Recurrence of presumed varicella-zoster virus retinopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1993) 0.89
Varicella-zoster virus and cerebral aneurysm: case report and review of the literature. Clin Infect Dis (2008) 0.89
Segmental zoster paresis of limbs. Electromyogr Clin Neurophysiol (1996) 0.88
Herpes zoster ophthalmoplegia. Report of six cases. J Clin Neuroophthalmol (1988) 0.87
Delayed oculomotor nerve palsy after bilateral cervical zoster in an immunocompetent patient. Neurology (2005) 0.87
Tooth exfoliation and osteonecrosis of the maxilla after trigeminal herpes zoster. J Pediatr (1985) 0.85
Presentations of cranial nerve involvement in two patients with Herpes zoster ophthalmicus. J Commun Dis (2001) 0.85
Herpes Zoster in the elderly. Postgrad Med (1971) 0.85
VZV molecular epidemiology. Curr Top Microbiol Immunol (2010) 0.83
Progressive outer retinal necrosis syndrome: a comprehensive review of its clinical presentation, relationship to immune system status, and management. Clin Eye Vis Care (2000) 0.83
[Bilateral acute retinal necrosis in a patient with acquired immunodeficiency syndrome]. J Fr Ophtalmol (1995) 0.83
Acute retinal necrosis. Semin Ophthalmol (2005) 0.83
Ramsay Hunt syndrome presenting as a cranial polyneuropathy. Cutis (1996) 0.82
Transverse myelitis caused by Varicella. Clin Neurol Neurosurg (2001) 0.82
Concurrent myelitis and Guillain-Barré syndrome after varicella infection. Int J Clin Pract (2001) 0.81
Persistent multiple pulmonary nodules in a nonimmunocompromised woman after varicella-related myelitis treated with acyclovir. J Clin Microbiol (2003) 0.81
MRI abnormalities in chronic active varicella zoster infection. Neurology (2004) 0.81
A woman with acute headache and sacral dermatomal numbness. J Clin Virol (2010) 0.81
Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia. J Neurovirol (2003) 0.81
Herpes zoster: an early manifestation of HIV infection. Afr Health (1998) 0.79
Mycotic aneurysm in angiitis associated with herpes zoster ophthalmicus. AJNR Am J Neuroradiol (1987) 0.78
Trigeminal herpes zoster causing mandibular osteonecrosis and spontaneous tooth exfoliation. South Med J (1986) 0.78
Progressive outer retinal necrosis after bone marrow transplantation. Am J Ophthalmol (1996) 0.78